{"id":"W2474670944","doi":"10.1097/01.jto.0000283407.07873.7c","title":"PD3-2-5: Preoperative gefitinib in clinical stage I NSCLC","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"","keywords":"Gefitinib; Medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Internal medicine; Epidermal growth factor receptor; Clinical endpoint; Adenocarcinoma; Cancer; Progressive disease; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004766433,0.0003992308,0.0008424143,0.0002927048,0.0003790447,0.0007576481,0.0002914028,0.0006094586,0.001754902],"category_scores_gemma":[0.00122348,0.0002340834,0.0004970358,0.0002653535,0.0003861256,0.0006099813,0.0002381127,0.001091111,0.0002992772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001113494,"about_ca_system_score_gemma":0.001035746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00164642,"about_ca_topic_score_gemma":0.006628916,"domain_scores_codex":[0.9997659,0.00006128289,0.00002649661,0.00003558423,0.00003227217,0.00007842059],"domain_scores_gemma":[0.9996592,0.0001120313,0.00004662379,0.00001316387,0.00001943832,0.0001495758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.09914444,0.001812444,0.3539745,0.0006352742,0.0008846353,0.006025438,0.0002850682,0.009883541,0.04637204,0.001704139,0.01632755,0.462951],"study_design_scores_gemma":[0.006576765,0.05595774,0.7996855,0.0003305815,0.002356222,0.02883231,0.0006344771,0.0165487,0.04318547,0.003251276,0.04239689,0.0002440169],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755888,0.01033107,0.0007775905,0.003019225,0.0003850709,0.00006610183,0.0003356362,0.00008314877,0.009413369],"genre_scores_gemma":[0.9972869,0.0009945006,0.0003957023,0.0002889556,0.000117575,0.00001696653,0.0002569921,0.000008214295,0.0006341632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001754902,"threshold_uncertainty_score":0.008078992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05042772656621752,"score_gpt":0.5477697998901098,"score_spread":0.4973420733238922,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}